Journal of the Pancreas is believed to be the most authenticated peer-reviewed journals on Cystic fibrosis. The journal is using Editorial Manager System for quality in peer review process. Journal of the Pancreas Editorial and reviewerâs team ensures the quality and rapid editorial, review processing with publishing time of just 21 days from the day of submission of manuscript.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects the lungs, pancreas, liver, and intestine. Its main characteristic is disrupted transport of chloride and sodium across an epithelium, which leads to thick, viscous secretions. It is also known as mucoviscidosis. Abnormal breathing is the most serious symptom which results from frequent lung infections. Cystic fibrosis is caused by a frameshift mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator. (CFTR). The name cystic fibrosis was given because there is a cyst formation in the Pancreas. The thick mucus secretion occurring due to cystic fibrosis block the way of digestive and endocrine enzymes of pancreas, causing a complete damage to pancreas.
OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 700+ peer-reviewed journals and has organized over 3000+ International Scientific Conferences all over the world. OMICS International journals have over 15 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50,000+ editorial board members and the rapid, quality and quick review processing.
Last date updated on June, 2014